January 2020 FDA Recall Pioglitazone And Metformin Hydrochloride by Macleods Pharma Usa Inc
D-0838-2020 - Subpotent Drug

This Class III drug recall was voluntarily initiated by Macleods Pharma Usa Inc on January 24, 2020 for the product Pioglitazone And Metformin Hydrochloride. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0838-2020

Reason for Recall
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Initiated
01-24-2020
Reported
02-12-2020
Quantity
4694 30x60-count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Macleods Pharma Usa Inc
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

Batch or Lot Expiration Information

Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020